Consent issues in the management of cerebrovascular diseases: A position paper of the American Academy of Neurology Ethics and Humanities Subcommittee

Neurology

Volumn 53, Issue 1, 1999, Pages 9-11

  Bernat, J L ^a   Beresford, H R ^a   Earnest, M P ^a   Goldblatt, D ^a   Mackin, G A ^a   McQuillen, M P ^a   Nelson, R F ^a   Nora, L M ^a   Snyder R D , Jr ^a   Taylor, R M ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CEREBROVASCULAR DISEASE; DIAGNOSTIC TEST; ETHICS; MEDICAL CARE; PATIENT CARE; PRIORITY JOURNAL; RESEARCH; TREATMENT PLANNING;

EID: 0033551462     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.53.1.9     Document Type: Article

References (20)

1. American Academy of Neurology Ethics and Humanities Subcommittee. Position statement: Certain aspects of the care and management of profoundly and irreversibly paralyzed patients with retained consciousness and cognition. Neurology 1993;43:222-223.
2. Bernat JL, Cranford RE, Kittredge FI Jr, Rosenberg RN. Competent patients with advanced states of permanent paralysis have the right to forgo life-sustaining therapy. Neurology 1993;43:224-225.
3. American Academy of Neurology Ethics and Humanities Subcommittee. Position of the American Academy of Neurology on certain aspects of the care and management of the persistent vegetative state patient. Neurology 1989;39:125-126.
4. American Academy of Neurology Ethics and Humanities Subcommittee. Ethical issues in the management of the demented patient. Neurology 1996;46:1180-1183.
5. Bernat JL, Goldstein ML, Viste KM, Jr. The neurologist and the dying patient. Neurology 1996;46:598-599.
6. American Academy of Neurology Ethics and Humanities Subcommittee. Palliative care in neurology. Neurology 1996;46: 870-872.
7. Gert B, Nelson WA, Culver CM. Moral theory and neurology. Neurol Clin 1989;7:681-696.
8. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587.
9. Quality Standards Subcommittee of the American Academy of Neurology. Practice advisory: thrombolytic therapy for acute ischemic stroke - summary statement. Neurology 1996;47: 835-839.
10. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991;325:445-453.
11. Wennberg DE, Lucas FL, Birkmeyer JD, Bredenberg CE, Fisher ES. Variation in carotid endarterectomy mortality in the Medicare population: trial hospitals, volume, and patient characteristics. JAMA 1998;279:1278-1281.
12. Nadeau SE. Decision analysis and carotid endarterectomy. J Stroke Cerebrovasc Dis 1993;3:244-255.
13. Riggs JE. Tissue-type plasminogen activator should not be used in ischemic stroke. Arch Neurol 1996;53:1306-1308.
14. American Academy of Neurology Ethics and Humanities Subcommittee. Ethical issues in clinical research in neurology: advancing knowledge and protecting human research subjects. Neurology 1998;50:592-595.
15. Bernat JL, Goldstein ML, Ringel SP. Conflicts of interest in neurology. Neurology 1998;50:327-331.
16. Miller FG, Rosenstein DL, DeRenzo EG. Professional integrity in clinical research. JAMA 1998;280:1449-1454.
17. American College of Physicians. Cognitively impaired subjects. Ann Intern Med 1989;111:843-848.
18. TD v New York State Office of Mental Health and Department of Health, 228 AD 2nd 95 (App. Div., First Dept., 5 Dec 1996).
19. Haimowitz S, Delano SJ, Oldham JM. Uninformed decision-making: the case of surrogate research consent. Hastings Cent Rep 1997;27(6):9-16.
20. Wichman A, Sandler AL. Research involving critically ill subjects in emergency circumstances: new regulations, new challenges. Neurology 1997;48:1151-1157.